Ziren Kong

Chinese Academy of Medical Sciences & Peking Union Medical College — China

Medicine · Health Sciences

21h-index1.2kcitations84works5.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(39), Thyroid Cancer Diagnosis and Treatment(25), Radiomics and Machine Learning in Medical Imaging(16), Medical Imaging Techniques and Applications(9), Brain Metastases and Treatment(9)

Publications84 total

Targeting metabolic mechanisms to overcome temozolomide resistance in glioblastoma
Discover Oncology·2026Open Access
Elucidating the causal relationships between cerebrospinal fluid metabolites and glioblastoma insights from mendelian randomization study
Neurosurgical Review·2026
Publisher Correction: Covalent targeted radioligands potentiate radionuclide therapy
Nature·2025Open Access
Porphyrin-Engineered <sup>125</sup>I-Nanoseeds as a Prototype for Immunogenic Brachytherapy
Journal of the American Chemical Society·2025· 5 cited
Supplementary Table 9 from CTR-FAPI PET Enables Precision Management of Medullary Thyroid Carcinoma
2025Open Access
Supplementary Table 3 from CTR-FAPI PET Enables Precision Management of Medullary Thyroid Carcinoma
2025Open Access
Supplementary Table 13 from CTR-FAPI PET Enables Precision Management of Medullary Thyroid Carcinoma
2025Open Access
Supplementary Table 5 from CTR-FAPI PET Enables Precision Management of Medullary Thyroid Carcinoma
2025Open Access
Supplementary Table 7 from CTR-FAPI PET Enables Precision Management of Medullary Thyroid Carcinoma
2025Open Access
Supplementary Figure 3 from CTR-FAPI PET Enables Precision Management of Medullary Thyroid Carcinoma
2025Open Access
Notification to AttendingPhysician from CTR-FAPI PET Enables Precision Management of Medullary Thyroid Carcinoma
2025Open Access
Supplementary Table 4 from CTR-FAPI PET Enables Precision Management of Medullary Thyroid Carcinoma
2025Open Access
Supplementary Table 14 from CTR-FAPI PET Enables Precision Management of Medullary Thyroid Carcinoma
2025Open Access
Supplementary Table 1 from CTR-FAPI PET Enables Precision Management of Medullary Thyroid Carcinoma
2025Open Access
Clinical Protocol from CTR-FAPI PET Enables Precision Management of Medullary Thyroid Carcinoma
2025Open Access
Supplementary Table 2 from CTR-FAPI PET Enables Precision Management of Medullary Thyroid Carcinoma
2025Open Access
Supplementary Table 12 from CTR-FAPI PET Enables Precision Management of Medullary Thyroid Carcinoma
2025Open Access
Supplementary Figure 1 from CTR-FAPI PET Enables Precision Management of Medullary Thyroid Carcinoma
2025Open Access
Supplementary Table 10 from CTR-FAPI PET Enables Precision Management of Medullary Thyroid Carcinoma
2025Open Access
Data from CTR-FAPI PET Enables Precision Management of Medullary Thyroid Carcinoma
2025Open Access
page 1 of 5Next →

Frequent Co-authors

Wenbin Ma(31), Yu Wang(20), Yaning Wang(16), Wenlin Chen(16), Xin Cheng(12), Junyi Chen(11), Yuekun Wang(11), Zhibo Liu(11), Zhi Yang(9), Penghao Liu(9), Delin Liu(9), Congxin Dai(8), Chendan Jiang(7), Dachun Zhao(7), Shaoyan Liu(7), Feng Feng(6), Nan Li(6), Mengxin Xu(5), Sirui Liu(5), Yiwei Zhang(4)